Prostate Health Index (PHI)

Senior Consultant Urologist & Robotic Surgeon

What is the Prostate Health Index (PHI)?

The Prostate Health Index (PHI) is a blood test that helps assess the risk of prostate cancer. It combines three prostate-specific measurements:

Total PSA (tPSA): Total PSA measures the overall level of prostate-specific antigen in the blood. PSA is a protein produced by both normal and cancerous prostate cells, and elevated levels can indicate prostate abnormalities, including cancer, benign prostatic hyperplasia (BPH), and prostatitis.
Free PSA (fPSA): Free PSA refers to the amount of prostate-specific antigen in the blood that is not bound to proteins. The ratio of free PSA to total PSA can help differentiate between prostate cancer and benign conditions. Typically, a lower ratio of free PSA to total PSA suggests a higher risk of prostate cancer.
[-2]proPSA (p2PSA): [-2]proPSA is a specific isoform of PSA that is more closely associated with prostate cancer. Higher levels of [-2]proPSA in the blood are linked to a greater likelihood of prostate cancer, making it a crucial component of the PHI test.

The PHI score is calculated using these three measurements through a proprietary formula: ([-2]proPSA / fPSA) x √tPSA. This calculation results in a single score that provides a more accurate risk assessment for prostate cancer than any of the individual measurements alone.

Purpose of Prostate Health Index (PHI)

The Prostate Health Index (PHI) serves several important purposes in the diagnosis and management of prostate health:

Enhanced Cancer Detection

PHI improves the accuracy of detecting prostate cancer, especially in men with borderline or moderately elevated PSA levels. By combining multiple PSA-related measurements, it provides a more reliable risk assessment.

Reducing Unnecessary Biopsies

Traditional PSA testing can lead to a high number of false positives, resulting in unnecessary biopsies. PHI helps to better differentiate between benign conditions and cancer, thus reducing the number of unnecessary invasive procedures.

Risk Stratification

PHI aids in stratifying patients based on their risk of having prostate cancer. This helps doctors make more informed decisions about whether to proceed with a biopsy or to monitor the patient with regular follow-up tests.

Guiding Clinical Decisions

The PHI score can be used alongside other clinical information to guide treatment decisions, helping to determine the need for further diagnostic testing or therapeutic interventions.

Monitoring Prostate Health

For men under active surveillance for prostate cancer, PHI can be a useful tool for monitoring changes in prostate health over time.

Who Should Consider the Prostate Health Index (PHI) Test?

The Prostate Health Index (PHI) test is particularly beneficial for certain groups of men who are at risk for prostate cancer or are experiencing symptoms that warrant further investigation. Here are the key groups who should consider the PHI test:

Men with Elevated PSA Levels

Men with PSA levels in the borderline or moderately elevated range (typically 4-10 ng/mL) who require further evaluation to distinguish between benign conditions and potential malignancies.

Men with a Family History of Prostate Cancer

Those with a strong family history of prostate cancer may benefit from the PHI test as part of their routine screening to detect any early signs of the disease.

Abnormal Digital Rectal Exam (DRE) Findings

If a DRE reveals abnormalities in the prostate, the PHI test can provide additional information to assess cancer risk.

Men Considering a Biopsy

Before proceeding with a prostate biopsy, the PHI test can help determine the necessity of the procedure by providing a more accurate risk assessment.

Men Experiencing Prostate Symptoms

Men with symptoms such as difficulty urinating, frequent urination, or pelvic pain who have borderline PSA levels, may use the PHI test to better understand their prostate health.

How is the Prostate Health Index (PHI) Test Conducted?

The Prostate Health Index (PHI) test is a straightforward and minimally invasive procedure. Here are the steps involved:

Consultation

The process begins with a consultation with a doctor, who will evaluate the patient’s medical history, symptoms, and risk factors to determine if the PHI test is appropriate.

Blood Sample Collection

The PHI test requires a blood sample, which is typically drawn from a vein in the arm. The procedure is similar to other routine blood tests and takes only a few minutes.

Laboratory Analysis

The blood sample is sent to a laboratory where the levels of total PSA (tPSA), free PSA (fPSA), and [-2]proPSA (p2PSA) are measured. The laboratory uses these measurements to calculate the PHI score.

Understanding Prostate Health Index (PHI) Results

The Prostate Health Index (PHI) results provide a numerical score that helps to evaluate a man’s risk of having prostate cancer. Here’s how to understand these results:

Low Risk: A lower PHI score suggests a lower risk of prostate cancer. Patients with low scores may not require immediate biopsy and can be monitored with regular follow-up tests.
Intermediate Risk: An intermediate PHI score indicates a moderate risk of prostate cancer. The doctor may recommend further diagnostic testing, such as imaging studies or a biopsy, based on the patient’s overall risk profile and clinical findings.
High Risk: A high PHI score indicates a higher probability of prostate cancer. Patients with high scores are typically advised to undergo a biopsy to confirm the presence of cancer and to determine the appropriate course of action.

Limitations of the Prostate Health Index (PHI) Test

Not a Standalone Diagnostic Tool: While the PHI test improves risk assessment, it is not definitive. A high PHI score indicates an increased risk of prostate cancer, but a biopsy is still needed to confirm the diagnosis.
False-Negative Results: Although the PHI test reduces false positives, false-negative results, where the test indicates a low risk despite the presence of cancer, are still possible.

Our clinics are under the following

insurance panels

For Singaporeans, Singapore Permanent Residents and Foreigners.
Please speak to our friendly clinic staff about using your insurance plans.

Reach Out To Us

We are committed to providing a one-stop experience, where you’ll receive a meticulous consultation and high-quality service in a comfortable environment.

Get Started

Book An Appointment

Prostate Health Index (PHI)

Frequently Asked
Questions

How does the PHI test differ from a standard PSA test?

The PHI test offers greater accuracy by integrating multiple PSA measurements, reducing the likelihood of false-positive results, and better distinguishing between benign prostate conditions and potential malignancies compared to the standard PSA test.

What do PHI test results indicate?

PHI test results provide a score that helps to stratify a man’s risk of having prostate cancer. Higher PHI scores indicate a higher likelihood of prostate cancer, while lower scores suggest a lower risk. The results should be interpreted in the context of other clinical findings.

Are there any risks associated with the PHI test?

The PHI test involves a routine blood draw, which carries minimal risks, such as slight bruising or discomfort at the puncture site. There are no significant risks associated with the test itself.

How long does it take to get PHI test results?

Depending on the laboratory’s processing time, PHI test results are typically available within a few days to a week. Your doctor will discuss the results with you once they are available.

How accurate is the PHI test?

The PHI test is more accurate than the standard PSA test in assessing prostate cancer risk, reducing false positives, and providing a clearer indication of whether a biopsy is needed.

Prostate Health Index (PHI)

What is the Prostate Health Index (PHI)?